99 related articles for article (PubMed ID: 11305115)
1. Pharmacologic inhibitors of MKK1 and MKK2.
Ahn NG; Nahreini TS; Tolwinski NS; Resing KA
Methods Enzymol; 2001; 332():417-31. PubMed ID: 11305115
[No Abstract] [Full Text] [Related]
2. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry.
Lewis TS; Hunt JB; Aveline LD; Jonscher KR; Louie DF; Yeh JM; Nahreini TS; Resing KA; Ahn NG
Mol Cell; 2000 Dec; 6(6):1343-54. PubMed ID: 11163208
[TBL] [Abstract][Full Text] [Related]
4. The role of MKK1/2 kinase activity in human cytomegalovirus infection.
Johnson RA; Ma XL; Yurochko AD; Huang ES
J Gen Virol; 2001 Mar; 82(Pt 3):493-497. PubMed ID: 11172089
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2.
Wu J; Harrison JK; Dent P; Lynch KR; Weber MJ; Sturgill TW
Mol Cell Biol; 1993 Aug; 13(8):4539-48. PubMed ID: 8393135
[TBL] [Abstract][Full Text] [Related]
6. Blockades of mitogen-activated protein kinase and calcineurin both change fibre-type markers in skeletal muscle culture.
Higginson J; Wackerhage H; Woods N; Schjerling P; Ratkevicius A; Grunnet N; Quistorff B
Pflugers Arch; 2002 Dec; 445(3):437-43. PubMed ID: 12466948
[TBL] [Abstract][Full Text] [Related]
7. The MPM-2 antibody inhibits mitogen-activated protein kinase activity by binding to an epitope containing phosphothreonine-183.
Taagepera S; Dent P; Her JH; Sturgill TW; Gorbsky GJ
Mol Biol Cell; 1994 Nov; 5(11):1243-51. PubMed ID: 7532473
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.
Waskiewicz AJ; Flynn A; Proud CG; Cooper JA
EMBO J; 1997 Apr; 16(8):1909-20. PubMed ID: 9155017
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of ERKs to focal adhesions by PKC epsilon is required for PMA-induced adhesion and migration of human glioma cells.
Besson A; Davy A; Robbins SM; Yong VW
Oncogene; 2001 Nov; 20(50):7398-407. PubMed ID: 11704869
[TBL] [Abstract][Full Text] [Related]
10. Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells.
Grant ER; Errico MA; Emanuel SL; Benjamin D; McMillian MK; Wadsworth SA; Zivin RA; Zhong Z
Biochem Pharmacol; 2001 Aug; 62(3):283-96. PubMed ID: 11434901
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes.
Engelman JA; Berg AH; Lewis RY; Lisanti MP; Scherer PE
Mol Endocrinol; 2000 Oct; 14(10):1557-69. PubMed ID: 11043572
[TBL] [Abstract][Full Text] [Related]
12. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of farnesyl protein transferase and MEK1,2 induce apoptosis in fibroblasts transformed with farnesylated but not geranylgeranylated H-Ras.
Brassard DL; English JM; Malkowski M; Kirschmeier P; Nagabhushan TL; Bishop WR
Exp Cell Res; 2002 Feb; 273(2):138-46. PubMed ID: 11822869
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells.
Woods SA; McGlade CJ; Guha A
Neuro Oncol; 2002 Oct; 4(4):242-52. PubMed ID: 12356354
[TBL] [Abstract][Full Text] [Related]
15. MEK-1/2 inhibition reduces branching morphogenesis and causes mesenchymal cell apoptosis in fetal rat lungs.
Kling DE; Lorenzo HK; Trbovich AM; Kinane TB; Donahoe PK; Schnitzer JJ
Am J Physiol Lung Cell Mol Physiol; 2002 Mar; 282(3):L370-8. PubMed ID: 11839529
[TBL] [Abstract][Full Text] [Related]
16. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion.
Jones NC; Fedorov YV; Rosenthal RS; Olwin BB
J Cell Physiol; 2001 Jan; 186(1):104-15. PubMed ID: 11147804
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation regulates nucleophosmin targeting to the centrosome during mitosis as detected by cross-reactive phosphorylation-specific MKK1/MKK2 antibodies.
Cha H; Hancock C; Dangi S; Maiguel D; Carrier F; Shapiro P
Biochem J; 2004 Mar; 378(Pt 3):857-65. PubMed ID: 14670079
[TBL] [Abstract][Full Text] [Related]
18. Cerulein-induced acute pancreatitis in the rat is significantly ameliorated by treatment with MEK1/2 inhibitors U0126 and PD98059.
Clemons AP; Holstein DM; Galli A; Saunders C
Pancreas; 2002 Oct; 25(3):251-9. PubMed ID: 12370536
[TBL] [Abstract][Full Text] [Related]
19. MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase.
Xu S; Robbins D; Frost J; Dang A; Lange-Carter C; Cobb MH
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6808-12. PubMed ID: 7624324
[TBL] [Abstract][Full Text] [Related]
20. Dual role for mitogen-activated protein kinase (Erk) in insulin-dependent regulation of Fra-1 (fos-related antigen-1) transcription and phosphorylation.
Hurd TW; Culbert AA; Webster KJ; Tavaré JM
Biochem J; 2002 Dec; 368(Pt 2):573-80. PubMed ID: 12197835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
